Astal Laboratories Adjusts Evaluation Amid Strong Sales Growth and Management Efficiency Challenges

Nov 07 2025 08:06 AM IST
share
Share Via
Astal Laboratories has recently adjusted its evaluation, reflecting changes in the stock's technical landscape. The company boasts strong financial metrics, including a low Debt to Equity ratio and impressive growth in net sales and operating profit. However, it faces challenges in management efficiency, as indicated by its Return on Equity.
Astal Laboratories Adjusts Evaluation Amid Strong Sales Growth and Management Efficiency Challenges Astal Laboratories, a microcap company in the Trading & Distributors industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, with indicators showing a transition from a bullish to a mildly bullish trend.

The company has demonstrated notable financial metrics, including a low Debt to Equity ratio of 0.07 times, which suggests a manageable level of debt relative to equity. Astal Laboratories has reported impressive growth in net sales, achieving an annual growth rate of 138.66%, alongside a significant operating profit increase of 70.72%. The latest quarter's net sales reached Rs 25.33 crore, contributing to a positive trajectory over the past six quarters.

Despite these strengths, the company faces challenges in management efficiency, as indicated by a Return on Equity (ROE) of 7.04%. This figure highlights a lower profitability per unit of shareholders' funds. The stock is currently trading at a premium compared to its peers' average historical valuations, reflecting its market position.

For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Astal Laboratories Ltd falling/rising?
Jan 13 2026 12:59 AM IST
share
Share Via
Astal Laboratories Ltd is Rated Sell
Jan 12 2026 10:10 AM IST
share
Share Via
Astal Laboratories Ltd is Rated Hold
Dec 25 2025 03:12 PM IST
share
Share Via
Is Astal Lab overvalued or undervalued?
Dec 04 2025 08:18 AM IST
share
Share Via
How has been the historical performance of Astal Lab?
Dec 03 2025 10:45 PM IST
share
Share Via